Scrip is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction
Brought to you by

Sorrento buys pain start-up Sherrington in stock deal worth $1.7mm

Executive Summary

Spec pharma Sorrento Therapeutics Inc. issued 200k common shares (valued at $1.7mm) to acquire private pain therapeutics start-up Sherrington Pharmaceuticals Inc.
Deal Industry
  • Biotechnology
    • Drug Discovery Tools
      • Molecular Diversity
        • Natural Products
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Acquisition
    • Intra-Biotech Deal
    • Acquisition of Private Biotech
    • Includes Contract
    • Payment Includes Stock
    • Full Acquisition

Related Companies

Advertisement
UsernamePublicRestriction

Register